Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Ca
Semaglutide 2.4 mg significantly lowers the risk of heart attacks, strokes, and mortality in ASCVD patients with overweight or obesity. This study highlights its broad benefits beyond diabetes management.
Alcohol and Cannabis Use Disorders Linked to Poorer Treatment Response in Adult ADHD, Small Study Finds
This study examines adult ADHD cannabis use disorder treatment response and finds that comorbid alcohol and cannabis use disorders reduce odds of clinical improvement. The small retrospective cohort highlights challenges in pharmacological treatment…
Exploring GLP-1 Receptor Agonists for Addiction Treatment
GLP-1 receptor agonists addiction benefits are emerging as a promising area in addiction medicine. These medications may reduce cravings and addictive behaviors by modulating brain reward pathways. Research continues to explore their potential beyond…
Evidence-Based Consensus on Pharmacological Management of Cannabis Dependence
The British Association for Psychopharmacology provides cannabis dependence pharmacological management guidelines based on current evidence. These guidelines highlight the limited pharmacological options and emphasize behavioral interventions. Clinicians…
